Dr. John Magnani presents "Novel Mechanisms in Glycobiology are New Sources of Therapeutics Drugs now in Clinical Trials in Cancer and Inflammatory Disorders"

Center for Life Science Building (Blackfan Circle), rooms 11081A & B, Boston
John Magnani

Dr. John Magnani, PhD is the Director, Chief Scientific Officer and SVP Research of GlycoMimetics, Inc (Bethesda, MD).
He will be presenting a seminar on Tuesday, July 23, 2019 titled:
“Novel Mechanisms in Glycobiology are New Sources of Therapeutics Drugs now in Clinical Trials in Cancer and Inflammatory Disorders”.

Room capacity is 50 people only.
Please Register by July 12th on the Eventbrite page and
contact Lisa Sumner, lsumner@bidmc.harvard.edu if you have any questions.

This event is sponsored by:
The National Center for Functional Glycomics
Harvard Medical School Center for Glycoscience
Beth Israel Deaconess Medical Center